CD274 and glioblastoma: By converting cold GBM into hot tumors with high infiltration of antitumor immune cells through the induction of ICD, removal of immunosuppressive MSDCs, and reduction of PD-L1 expression on tumor cells, the combination of epirubicin-loaded micelles with aPD1 eliminated GBM resistance to ICI (65).